SANC00497



3β-[(β-D-Glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-β-D-xylopyranosyl-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one





C45H72O18





901.04









263570-75-8







[H][C@@]7(O[C@H]6[C@@H](O)CO[C@@]([H])(O[C@H]5C[C@@]4([H])[C@]3([H])CC=C2C[C@@H](O[C@]1([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)CC[C@]2(C)[C@@]3([H])CC[C@]4(C)[C@@]5(O)[C@H](C)C(=O)CCC(C)C)[C@@H]6OC(C)=O)OC[C@@H](O)[C@H](O)[C@H]7O





  • Cholestane

  • Glycoside

  • Steroids and steroid derivatives (Classyfire)


  • Cholest-5-En-22-One, 16-[(2-O-Acetyl-3-O-[Beta]-D-Xylopyranosyl-[Alpha]-L-Arabinopyranosyl)Oxy]-3-([Beta]-D-Glucopyranosyloxy)-17-Hydroxy-, (3[Beta],16[Beta])-
  • 3[Beta]-[([Beta]-D-Glucopyranosyl)Oxy]-17[Alpha]-Hydroxy-16[Beta]-[(O-[Beta]-D-Xylopyranosyl-(1[To]2)-2-O-Acetyl-[Alpha]-L-Arabinopyranosyl)Oxy]Cholest-5-En-22-One


  • Galtonia candicans

  • Cytotoxic activity on HL-60 leukemia cells